With promise to slow aging and cure some types of cancer, a new gene therapy presents cost and access hurdles for CT patients.
Detailed price information for Ultragenyx Pharmaceu (RARE-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results